Joenja is a sizeable contributor to Pharming's revenues, accounting for €38 million ($45 million) of its total sales of €70 ...

Both products can be used in the UK to provide protection against RSV disease in certain settings. Abrysvo was cleared for ...

Venglustat is designed to reduce the toxic build-up, and the new trial showed that a daily dose of the drug achieved ...

Eli Lilly has revealed the fourth new manufacturing site in its $27 billion capital investment spree in the US – a $3.5 ...

Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...

The FDA has started accepting requests to participate in its PreCheck pilot programme, designed to make it easier and quicker ...

As this complexity deepens, a simple truth emerges: classical measurement frameworks cannot keep pace with a system that is no longer linear, nor even merely non-linear, but fundamentally ...

Acute pancreatitis is linked to the development of gallstones, which are listed as a side effect with GLP-1 drugs. Ahmed said ...

The new announcements bring the number of IPOs priced this week to four, coming shortly after South San Francisco ...

Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, ...

The South San Francisco start-up is offering 17.6 million shares at a price range of $16 to $18, which would give the company ...

On behalf of Lilly, Seamless will design and programme recombinases that can correct alterations in multiple genes involved ...